VALNEVA (EPA:VLA) | Finanzwire

PRESS RELEASE

published on 04/09/2025 at 07:00, 11 months 17 days ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease

Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Valneva SE reports solid full year 2024 results exceeding growth targets. Financial outlook for 2025 includes strong revenue growth and strategic investments. Key milestones and financial information discussed

Financial Results Valneva 2025 Outlook Vaccine Company Clinical Progress
BRIEF

published on 02/05/2025 at 07:05, 1 year 1 month ago

Valneva Achieves UK Approval for World's First Chikungunya Vaccine

Public Health Valneva Chikungunya Vaccine UK Approval Travel Safety
PRESS RELEASE

published on 02/05/2025 at 07:00, 1 year 1 month ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year 3 months ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year 3 months ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 1 year 3 months ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 1 year 3 months ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 3 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 1 year 3 months ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence

Published on 03/26/2026 at 11:00, 8 minutes ago

Pivotree Announces Fourth Quarter 2025 Results
Published on 03/26/2026 at 08:05, 3 hours 3 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 13 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 10 hours 28 minutes ago

Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 10 hours 38 minutes ago

Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results

View all ACCESSWIRE

Published on 03/26/2026 at 10:45, 23 minutes ago

Nonstop in 11 Hours to the 'City of Pandas': Chengdu Launches Direct Flights to Brussels
Published on 03/26/2026 at 10:30, 37 minutes ago

Cando Solar introduces solar wing solution "Cando Solar Cloth," making scalable and lightweight solar power a reality
Published on 03/26/2026 at 10:05, 1 hour 2 minutes ago

Holding(s) in Company
Published on 03/26/2026 at 10:05, 1 hour 2 minutes ago

'SOMEBODY TOLD ME' THE KILLERS ARE HEADLINING THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Published on 03/26/2026 at 10:00, 1 hour 7 minutes ago

No Limits, Just Beginnings: NAVEE Enters a New Performance Era in Germany

View all EQS

Published on 03/26/2026 at 08:57, 2 hours 10 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 3 hours 38 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 16 hours 14 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 16 hours 37 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 23 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

News